Active Surveillance for Low-Risk Cancers — A Viable Solution to Overtreatment?

The excellent prognosis associated with most low-risk cancers combined with the potential for avoiding treatment side effects make active surveillance a promising alternative to more intensive approaches. But achieving widespread adoption will require further work.